(Q34481636)

2 August 2017

1 reference

title

Experimental and emerging therapies for sepsis and septic shock (English)

1 reference

2 August 2017

0 references

1 reference

Añel RL

1

1 reference

PubMed ID

11772263

2 August 2017

Kumar A

series ordinal

2

1 reference

PubMed ID

11772263

2 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

1471-1485

1 reference

2 August 2017

8

1 reference

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

PROTECTION OF ADRENALECTOMIZED ANIMALS AGAINST BACTERIAL INTOXICATION BY AN EXTRACT OF THE ADRENAL CORTEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Steroid controversy in sepsis and septic shock: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Immunological therapy in sepsis: currently available

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose Dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Reversal of late septic shock with supraphysiologic doses of hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Adrenal insufficiency during the late stage of polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Anticytokine strategies in the treatment of the systemic inflammatory response syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Protein C and the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

A simple multiple system organ failure scoring system predicts mortality of patients who have sepsis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Endotoxin releases platelet-activating factor from human monocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Relationships between tumour necrosis factor, eicosanoids and platelet-activating factor as mediators of endotoxin-induced shock in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

A double-blind placebo-controlled study of an infusion of lexipafant (Platelet-activating factor receptor antagonist) in patients with severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Platelet-activating factor acetylhydrolases in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Nitric oxide in cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Nitric oxide scavengers as a therapeutic approach to nitric oxide mediated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Apoptosis in sepsis: a new target for therapeutic exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Neuroprotection by a caspase inhibitor in acute bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Prevention of lymphocyte cell death in sepsis improves survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

PAF. A review of its effects, antagonists and possible future clinical implications (Part II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1471

10.1517/13543784.10.8.1471

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11772263